Koligo Therapeutics (ASX:KOL) Interest Expense: A$ Mil (TTM As of . 20)


What is Koligo Therapeutics Interest Expense?

Koligo Therapeutics ASX:KOL Interest Expense is A$ Mil as of . 20.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Koligo Therapeutics's interest expense for the six months ended in . 20 was A$ 0.00 Mil. Koligo Therapeutics does not have enough years/quarters to calculate its interest expense for the trailing twelve months (TTM) ended in . 20.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Koligo Therapeutics's Operating Income for the six months ended in . 20 was A$ 0.00 Mil. Koligo Therapeutics's Interest Expense for the six months ended in . 20 was A$ 0.00 Mil. Koligo Therapeutics did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Koligo Therapeutics  (ASX:KOL) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Koligo Therapeutics's Interest Expense for the six months ended in . 20 was A$0.00 Mil. Its Operating Income for the six months ended in . 20 was A$0.00 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in . 20 was A$0.00 Mil.

Koligo Therapeutics's Interest Coverage for the quarter that ended in . 20 is calculated as

Koligo Therapeutics had no long-term debt (1).

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Koligo Therapeutics Interest Expense Historical Data

* Premium members only.

The historical data trend for Koligo Therapeutics's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Koligo Therapeutics Interest Expense Chart

Koligo Therapeutics Annual Data
Trend
Interest Expense

Koligo Therapeutics Semi-Annual Data
Interest Expense

Koligo Therapeutics Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of A$ Mil mean?
Koligo Therapeutics (ASX:KOL) has a Interest Expense of A$ Mil as of . 20. Interest Expense is the amount a company pays on its long-term debt. View historical data on Koligo Therapeutics and its competitors.
Is Koligo Therapeutics' Interest Expense too high?
Koligo Therapeutics' current Interest Expense is A$ Mil.
How does Koligo Therapeutics' Interest Expense compare to ?
Koligo Therapeutics' Interest Expense of A$ Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Biotechnology company?
A good Interest Expense depends on the Biotechnology industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Koligo Therapeutics and its competitors. Koligo Therapeutics's current Interest Expense is A$ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Koligo Therapeutics stock overvalued right now?
Koligo Therapeutics (ASX:KOL) has a current Interest Expense of A$ Mil. The current Interest Expense is A$ Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Koligo Therapeutics (ASX:KOL), the current Interest Expense is A$ Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Koligo Therapeutics Business Description

Comparable Companies